Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(9%)
Results Posted
20%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph phase_1
1
9%
Ph not_applicable
6
55%
Ph phase_2
1
9%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
unknown3
Withdrawn1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 31 (11.1%)
N/A6 (66.7%)

Trials by Status

unknown327%
withdrawn19%
terminated19%
completed545%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_1

Valproate for the Treatment of Residual Amblyopia

NCT07226141
terminatednot_applicable

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

NCT02687581
unknownnot_applicable

A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia

NCT04238065
withdrawnnot_applicable

Monitoring Physiologic Data in the Development of Pressure Ulcers

NCT02689817
completed

Patch With Onion Extract and Allantoin for C-section Scar

NCT04046783
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07226141Phase 1

Valproate for the Treatment of Residual Amblyopia

Recruiting
NCT02687581Not Applicable

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Terminated
NCT04238065Not Applicable

A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia

Unknown
NCT02689817Not Applicable

Monitoring Physiologic Data in the Development of Pressure Ulcers

Withdrawn
NCT04046783

Patch With Onion Extract and Allantoin for C-section Scar

Completed
NCT02049684

SPARC: Shoulder PAtch for Rotator Cuff Tears

Completed
NCT03816566Not Applicable

Validation of a Wearable Non-invasive Device (the Patch)

Unknown
NCT02955576Not Applicable

Microneedle Patch for Psoriatic Plaques

Unknown
NCT01226108Not Applicable

The Akloma Tinnitus Patch in Patients With Manifested Tinnitus

Completed
NCT00777374Phase 2

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration

Completed
NCT00001864Phase 3

Amblyopia (Lazy Eye) Treatment Study

Completed

All 11 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11